Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:50 pm Purchase |
2021-12-31 | 13G | Mereo BioPharma Group plc MREO |
Point72 Asset Management, L.P. | 10,610,000 9.100% |
3,710,331 (+53.78%) |
Filing History |
| 2022-02-14 4:49 pm Purchase |
2021-12-31 | 13G | Krystal Biotech, Inc. KRYS |
Point72 Asset Management, L.P. | 1,860,670 7.500% |
517,428 (+38.52%) |
Filing History |
| 2022-02-14 4:49 pm Sale |
2021-12-31 | 13G | Kindred Biosciences, Inc. KIN |
Point72 Asset Management, L.P. | 0 0.000% |
-3,858,103 (Position Closed) |
Filing History |
| 2022-02-14 4:48 pm Sale |
2021-12-31 | 13G | Kadmon Holdings, Inc. KDMN |
Point72 Asset Management, L.P. | 0 0.000% |
-9,083,336 (Position Closed) |
Filing History |
| 2022-02-14 4:47 pm Purchase |
2021-12-31 | 13G | Growth Capital Acquisition Corp. GCAC |
Point72 Asset Management, L.P. | 1,491,609 8.600% |
411,185 (+38.06%) |
Filing History |
| 2022-02-14 4:46 pm Sale |
2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
Point72 Asset Management, L.P. | 225,463 0.300% |
-2,999,111 (-93.01%) |
Filing History |
| 2022-02-14 4:45 pm Sale |
2021-12-31 | 13G | F-star Therapeutics, Inc. FSTX |
Point72 Asset Management, L.P. | 987,111 4.800% |
-112,889 (-10.26%) |
Filing History |
| 2022-02-14 4:44 pm Sale |
2021-12-31 | 13G | Oyster Point Pharma, Inc. OYST |
Point72 Asset Management, L.P. | 2,104,202 8.000% |
-193,559 (-8.42%) |
Filing History |
| 2022-02-14 4:43 pm Sale |
2021-12-31 | 13G | Paya Holdings Inc. PAYA |
Point72 Asset Management, L.P. | 494,000 0.400% |
-5,965,793 (-92.35%) |
Filing History |
| 2022-02-14 4:43 pm Purchase |
2021-12-31 | 13G | CytomX Therapeutics, Inc. CTMX |
Point72 Asset Management, L.P. | 6,312,371 9.700% |
788,465 (+14.27%) |
Filing History |
| 2022-02-14 4:42 pm Sale |
2021-12-31 | 13G | Curis, Inc. CRIS |
Point72 Asset Management, L.P. | 80,158 1.800% |
-186,839 (-69.98%) |
Filing History |
| 2022-02-14 4:42 pm Sale |
2021-12-31 | 13G | Poshmark, Inc. POSH |
Point72 Asset Management, L.P. | 522,144 1.100% |
-361,703 (-40.92%) |
Filing History |
| 2022-02-14 4:41 pm Purchase |
2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Point72 Asset Management, L.P. | 215,902 6.500% |
5,902 (+2.81%) |
Filing History |
| 2022-02-14 4:41 pm Sale |
2021-12-31 | 13G | Revolve Group, Inc. RVLV |
Point72 Asset Management, L.P. | 237,221 0.600% |
-1,487,315 (-86.24%) |
Filing History |
| 2022-02-14 4:41 pm Purchase |
2021-12-31 | 13G | Chimerix, Inc. CMRX |
Point72 Asset Management, L.P. | 4,548,254 5.200% |
712,784 (+18.58%) |
Filing History |
| 2022-02-14 4:40 pm Purchase |
2021-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Point72 Asset Management, L.P. | 1,572,823 5.300% |
135,247 (+9.41%) |
Filing History |
| 2022-02-14 4:40 pm Sale |
2021-12-31 | 13G | Theravance Biopharma, Inc. TBPH |
Point72 Asset Management, L.P. | 228,922 0.300% |
-4,915,715 (-95.55%) |
Filing History |
| 2022-02-14 4:39 pm Sale |
2021-12-31 | 13G | BELLUS Health Inc. BLU |
Point72 Asset Management, L.P. | 56,430 0.100% |
-6,183,686 (-99.10%) |
Filing History |
| 2022-02-14 4:39 pm Purchase |
2021-12-31 | 13G | TRICIDA INC TCDAQ |
Point72 Asset Management, L.P. | 3,284,903 5.900% |
759,365 (+30.07%) |
Filing History |
| 2022-02-14 4:38 pm Purchase |
2021-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Point72 Asset Management, L.P. | 1,633,204 5.800% |
132,961 (+8.86%) |
Filing History |